[1]
Rajpoot, M., Singh, D., Pandey, K. and Bhargava, R. 2022. Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters? . Nepalese Journal of Ophthalmology. 14, 2 (Dec. 2022), 64–77. DOI:https://doi.org/10.3126/nepjoph.v14i2.38928.